Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants

W. Göpel*, C. Härtel, P. Ahrens, I. König, E. Kattner, E. Kuhls, H. Küster, J. Möller, D. Müller, B. Roth, H. Segerer, C. Wieg, E. Herting

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

We investigated the association between the interleukin 6 (IL-6)-174-genotype and unfavorable outcomes in preterm infants since it has been reported that the IL-6-174GG-genotype is associated with increased susceptibility to sepsis, and the IL-6-174CC-genotype is more common in preterm infants with severe intraventricular hemorrhage (IVH). We studied 1206 preterm infants with a birth weight below 1500 g. In contrast to previously published data, the frequency of IVH grade IV, periventricular leukomalacia, ventricular-peritoneal-shunting or death was not different between infants with different IL-6-genotypes: IL-6-174GG (n = 430) 8%, IL-6-174GC (n = 605) 9% and IL-6-174CC (n = 167) 12% (P = 0.2 for IL-6-174CC vs GG+GC). Furthermore, we were not able to confirm previously reported association between sepsis and the IL-6-174GG-genotype. Blood-culture-proven sepsis occurred in 19% of IL-6-174GG-carriers (n=157), 26% of IL-6-174GC-carriers (n = 193) and 27% of infants carrying the IL-6-174CC-genotype (n = 67). We were not able to confirm previously reported associations between sepsis, cerebral injury and the IL-6-174-genotype in VLBW-infants.

OriginalspracheEnglisch
ZeitschriftGenes and Immunity
Jahrgang7
Ausgabenummer1
Seiten (von - bis)65-68
Seitenumfang4
ISSN1466-4879
DOIs
PublikationsstatusVeröffentlicht - 01.2006

Fördermittel

The authors thank Anja Sewe and Sabine Ziesenitz for excellent laboratory assistance, Birgit Roenspiess and Anne Hoegemann for skillful data collection, all doctors and nurses of the participating hospitals, and especially all infants and their parents for their support. This work was supported by the Deutsche Forschungsge-meinschaft, Grant-no. Go955/1-3.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Interleukin-6-174-genotype, sepsis and cerebral injury in very low birth weight infants“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren